ER-319711

N/A

Report date: 2025/05/07 16:35:14
NME

Base Information

Drug NameER-319711
Drug Alias NameER-319711
ClassificationSmall molecules
Mechanisms of ActionDipeptidyl peptidase IV inhibitors
TargetsDipeptidyl peptidase IV
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesShiga University Of Medical Science
China Registration ClassN/A

Develop Information

Active CompaniesShiga University Of Medical Science
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A